Average Co-Inventor Count = 2.56
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (11 from 1,778 patents)
2. Other (1 from 832,912 patents)
12 patents:
1. 12514822 - Oral dosing of GLP-1 compounds
2. 12239739 - Oral dosing of GLP-1 compounds
3. 11382957 - Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
4. 11033499 - Tablet formulation comprising a GLP-1 peptide and a delivery agent
5. 10960052 - Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid
6. 10278923 - Oral dosing of GLP-1 compounds
7. 10265384 - Tablets comprising GLP-1 agonist and enteric coating
8. 10086047 - Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
9. 9993430 - Tablet formulation comprising semaglutide and a delivery agent
10. 9278123 - Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
11. 9040660 - Long-acting gastrin derivatives
12. 4372749 - Method for the manufacturing of fuel briquettes